You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | n/a |
| Div Cover | n/a | n/a |
| Op Mrgn | -1,043.5% | n/a |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -16.0 | n/a |
| PEG | 0.0 | n/a |
| Price / Revenue | 151.2 | n/a |
| Price / Book value | 4.4 |
| Latest | Forecast | |
|---|---|---|
| Revenue | -26.8% | n/a |
| PBT | 0.0% | n/a |
| EPS | 0.0% | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | 0.20 | -0.53 | -5.00p | 0.0 | 0.0 | n/a | n/a | 0.0% |
| 2020-12-31 | 0.46 | -0.72 | -8.00p | 0.0 | 0.0 | n/a | n/a | 0.0% |
| 2021-12-31 | 0.34 | -3.64 | -26.00p | -23.7 | 0.0 | n/a | n/a | 0.0% |
| 4basebio enters neurofibromatosis collaboration with two universities Sharecast News | 10 Jun |
|---|---|
| Losses to continue as 4basebio focuses on commercialisation Sharecast News | 09 May |
| 4basebio inks development deal with Heqet Therapeutics Sharecast News | 27 Apr |
| 4basebio Plc - Director/PDMR Shareholding | 16-Jun-22 15:29 |
|---|---|
| 4basebio Plc - Research Collaboration | 10-Jun-22 07:01 |
| 4basebio Plc - Result of AGM | 09-Jun-22 11:39 |
| 4basebio Plc - Director/PDMR Shareholding | 12-May-22 14:28 |
| 4basebio Plc - Director/PDMR Shareholding | 11-May-22 11:57 |